Pilot Study About Safety and Efficacy of Atomized Intrapleural Lidocaine During Pleuroscopy
Withdrawn before enrolling · Not applicable
Conditions studied: Pain
In brief
This study will evaluate the potential to decrease the use of IV anesthesia drugs in patients undergoing pleuroscopy administering lidocane standardly applied to the skin in combination with atomized lidocaine applied into the pleural cavity.
Key facts
- Study ID
- NCT00693043
- Run by
- Lahey Clinic
- People needed
- 0
- Starts
- 2008-02-01
- Expected to finish
- 2010-05-01
- Last updated by the study team
- 2017-12-26
Who can join
Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients diagnosed with pleural disease
- Patients undergoing pleuroscopy with talc with or w/o biopsy
- Patients aged 18 - 85
- Patients capable of signing informed consent
You may not qualify if…
- Severe congestive heart failure
- Hepatic failure, bilirubin > 2mg/dl, ALT,AST 3XULN
- Prior use Lidocaine in 48 hrs
- Hx SA drug reaction to lidocaine or amide local anesthetics
- Second or third degree heart block (w/o pacemaker)
- Sever sinoatrial block (w/o pacemaker)
- Concurrent treatment with quinidine, flecainide, dsopyramide, procainamide (ClassI antirrhythmic agents)
- Prior use or amiodarone hydrochloride
- systolic BP < 90mmHg
- bradycardia
- accelerated idioventricular rhythm
Where it is running
- Lahey Clinic — Burlington, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.